And I'd love to know whether you're headed to JPM24 and/or want to watch hockey
Plus thinking about the connection between jet fuel and obesity meds
So I can't even get to obesity or copay accumulators until tomorrow
Plus a must-read paper on what the IRA will do to formularies, and how that will impact patients
And the government is going to pay $85 or so for the new COVID-19 vaccines
And how tens of billions in 340B drug sales hinges on the definition of 'patient'
And a reminder: we could get some judicial action in an IRA case this week
Plus a brief detour to talk about how drugmakers disclose population size for new meds
And PhRMA has a new judge and AZ has a 'target date' for a decision in its case
Plus the early rumblings on how a shutdown with impact health policy
And elevating an interesting ICER gene therapy review that is flying below the radar
And almost everyone you can imagine just filed amicus briefs in the Merck IRA case